In the BioHarmony Drug Report Database

"Preview" Icon

Thyrotropin alfa

Thyrogen (thyrotropin alfa) is a protein pharmaceutical. Thyrotropin alfa was first approved as Thyrogen on 1998-11-30. It is used to treat thyroid neoplasms in the USA. It has been approved in Europe to treat thyroid neoplasms. The pharmaceutical is active against thyrotropin receptor.

 

Trade Name

 

Thyrogen
 

Common Name

 

thyrotropin alfa
 

ChEMBL ID

 

CHEMBL1201533
 

Indication

 

thyroid neoplasms
 

Drug Class

 

Tricyclic compounds; atropine derivatives

Image (chem structure or protein)

Thyrotropin alfa structure rendering